COVID may have been a godsend for these folks. It looks like it was an "out" for them, it allowed them to shift blame elsewhere and to buy 1.5 years of collecting a hefty salary -- and we were all duped.
Even with generics, TRx are under 100k.
Doc visits are back to nearly normal now -- what is their excuse for 83k (97k with generics) TRx for what is supposed to be a practice-changing drug?
Market Data 
Markets 
AI
